@jenniferaregala.bsky.social is at #ASTRO25! Stop by the WKHealth booth to say hello and learn more about Oncology Times—and learn how you can become a contributor.

Matthew Mangold, BSN, RN, a radiation oncology nurse at Fox Chase Cancer Center, is one of three finalists for a national nursing honor, the 2025 Extraordinary Healer award, which recognizes oncology nurses whose compassion improve the lives of their patients. ow.ly/TI0H50W7YPf #NationalNursesWeek

The June issue is out now! It features The Future of #ArtificialIntelligence & Regulatory Innovation, New #ASTRO Guidelines for Radiation in #RectalCancer, NK Cell Therapy to Improve Survival, and more. Read it here: ow.ly/awuJ50W2MAW

Three researchers from Fox Chase Cancer Center have been added to the 2024 list of Highly Cited Researchers by Clarivate. Read more here: ow.ly/T82p50VyA6r

New issue out now! The latest issue of Oncology Times covers key developments shaping cancer care, including commentary on nerve repair in mandible reconstruction and more. Read the April issue of Oncology Times online here: journals.lww.com/oncology-tim... #CancerResearch #Oncology #CancerCare

#ALamyloidosis is a rare condition characterized by the deposition of immunoglobulin light chains in organs. The ANDROMEDA study assessed the addition of DARA to the standard VCd regimen. Read the results: journals.lww.com/oncology-tim...

A new study found that #aspirin may reduce risk of disease recurrence by greater than 50% for some patients following surgery for #ColorectalCancer. Read more here: ow.ly/E1fU50VgwRk

PD-1 immunology drugs have failed to live up to their promise. Recent research suggests this is because of the animal models that formed the basis for the preclinical drug studies. Read more here: ow.ly/9y1e50VgwvS #CancerResearch

Kimberly Feigin, MD, has been named Chief of the Breast Imaging Service within the Department of Radiology at Memorial Sloan Kettering Cancer Center. ow.ly/sa3B50VcMcv

By detecting free-floating microscopic bits of DNA shed by tumors into the bloodstream, a team led by researchers at the Dana-Farber Cancer Institute was able to isolate a subset of patients with Stage III colon cancer who might significantly benefit from celecoxib. ow.ly/OVWp50Varf8

The #FDA granted accelerated approval to encorafenib with cetuximab and mFOLFOX6 for patients with metastatic #ColorectalCancer with a BRAF V600E mutation. ow.ly/6aIN50V7eFf

Looking for #podcasts covering the latest news in #oncology and #hematology? Listen to Oncology Times' OncTimes Talk podcast here: ow.ly/XX0I50V7Qyt

Luis, an 80-year-old with multiple myeloma, achieved a very good partial response with DRd but now faces treatment-related cytopenias and peripheral neuropathy, impacting adherence. How would you adjust his regimen? Explore the case and weigh in here: focusononcology.com/therapeutic-...

Recent research suggests that common anti-inflammatory drugs may counteract tumors' cloaking mechanisms, allowing immune cells to better identify and attack #tumorcells. This discovery provides a potential way to overcome one of cancer's key defenses. ow.ly/b6r950UVLvU

In high-risk smoldering #MultipleMyeloma, subcutaneous daratumumab reduced disease progression or death by 51% compared to active monitoring, improving 5-year survival (93% vs. 86.9%). ow.ly/jkwZ50V4Cyx

Can poor indoor air quality lead to #cancer? New findings suggest that poor air quality increases the risk of cancers affecting the airway, such as lung cancer, nasopharyngeal cancer, and laryngeal cancer. ow.ly/KgzR50V2cCe

Today is World #Cholangiocarcinoma Day. Early detection of this rare but aggressive #bileductcancer is critical, and research is paving the way for better treatments. Oncology Times is committed to supporting patients and ongoing research. #WorldCCADay

Recently, the Community Oncology Alliance introduced their Prescription for Health Care Reform. Ted Okon, executive director of COA, sat down with #OncologyTimes to discuss why the Prescription is needed. Watch it here: journals.lww.com/oncology-tim...

Adjuvant chest wall irradiation post-mastectomy in patients with intermediate-risk #breastcancer does not improve 10-year overall survival, according to highly anticipated data presented at #SABCS2024. ow.ly/gG9550UVLqi

Stephen D. Nimer, MD, Director of Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has been awarded the American Society of Hematology's Mentor Award for 2024. ow.ly/ewVX50UZEga

Belinda Avalos, MD, Professor of Medicine and a senior advisor to the President of Atrium Health Levine Cancer, will serve as President of ASH for a year-long term through December 2025. ow.ly/C25a50UXPcA

Oncology Times is on Bluesky! Follow to stay up to date on the latest cancer research, health news, and oncology and hematology content. You can read the latest issue here: journals.lww.com/oncology-tim...